M&A Deal Summary |
|
---|---|
Date | 2024-02-01 |
Target | Graviton Bioscience |
Sector | Life Science |
Buyer(s) | Sanofi |
Deal Type | Add-on Acquisition |
Advisor(s) | Cooley (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1994 |
Sector | Life Science |
Employees | 86,088 |
Revenue | 46.4B EUR (2023) |
Sanofi is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi was founded in 1994 and is based in Paris, France.
DEAL STATS | # |
---|---|
Overall | 27 of 27 |
Sector (Life Science) | 18 of 18 |
Type (Add-on Acquisition) | 21 of 21 |
State (New York) | 2 of 2 |
Country (United States) | 16 of 16 |
Year (2024) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-12-21 |
Amunix
South San Francisco, California, United States Amunix is an immuno-oncology company focused on designing and developing masked T cell engagers and cytokines to bring the promise of these potent immune-activating biotherapeutics to patients with cancers. Amunix is headquartered in South San Francisco, California. |
Buy | - |